Allergic Rhinitis and Its Impact on Work Productivity in Primary Care Practice and a Comparison with Other Common Diseases: The Cross-sectional Study to Evaluate Work Productivity in Allergic Rhinitis Compared with Other Common Diseases (CAPRI) Study

Abstract

Background

Allergic rhinitis (AR) is a highly prevalent allergic disease and also counts among the 10 most frequent reasons for medical consultation. Its impact on quality of life (QoL) and work productivity has been established but comparisons with other diseases are rare in the literature. The aim of this study was to evaluate the impact of AR in health-related QoL (HRQoL) and work productivity in primary care patients, compared with other prevalent diseases such as hypertension, diabetes mellitus (DM) type II, and symptomatic depression.

Methods

Six hundred sixteen patients were included in a multicenter cross-sectional observational study. A generic HRQoL questionnaire, 36-item Short Form, and a specific questionnaire, “Work Productivity and Activity Impairment” were handed out to measure QoL and work productivity impact of the diseases. To assess clinical severity with a comparable scale between diseases Clinical Global Impression (CGI) had been used.

Results

Symptomatic depression was found to produce the greatest impairment on work productivity with a decrease of 59.5%, with significant differences compared with AR, hypertension, and DM type II (p < 0.05). Symptomatic depression was found to produce the highest negative impact on daily activities with a statistically significant reduction of 59.4% (p < 0.05) compared with AR (26.6% decrease), hypertension (8.8% decrease), and DM (16.7% decrease) patients. Differences between AR and DM or hypertension were also significant (p < 0.05). Restriction on daily activities for AR was 27.8%, which is significantly higher (p < 0.05) than hypertension (19.8% decrease) but not DM (25.7% decrease). Depression had the highest impairment on daily activities (59.4%), compared with the remaining three groups (p < 0.05).

Conclusion

AR impairs work productivity in a greater magnitude than hypertension and DM type II.

Get full access to this article

View all access options for this article.

References

Canonica

Bousquet

Mullol

, A survey of the burden of allergic rhinitis in Europe. Allergy 62(suppl 85):17–25, 2007.

Bauchau

and Durham

. Prevalence and rate of diagnosis of allergic rhinitis in Europe. Eur Respir J 24:758–764, 2004.

Gupta

Sheikh

Strachan

, Burden of allergic disease in the UK: Secondary analyses of national databases. Clin Exp Allergy 34:520–526, 2004.

Anandan

Gupta

Simpson

, Epidemiology and disease burden from allergic disease in Scotland: analyses of national databases. J R Soc Med 102:431–442, 2009.

Bousquet

Bullinger

Fayol

, Assessment of quality of life in patients with perennial allergic rhinitis with the French version of the SF-36 Health Status Questionnaire. J Allergy Clin Immunol 94:182–188, 1994.

Blanc

Trupin

Eisner

, The work impact of asthma and rhinitis: Findings from a population-based survey. J Clin Epidemiol 54:610–618, 2001.

Benninger

and Benninger

. The impact of allergic rhinitis on sexual activity, sleep, and fatigue. Allergy Asthma Proc 30:358–365, 2009.

Lamb

Ratner

Johnson

, Economic impact of workplace productivity losses due to allergic rhinitis compared with select medical conditions in the United States from an employer perspective. Curr Med Res Opin 22:1203–1210, 2006.

Hellgren

Cervin

Nordling

, Allergic rhinitis and the common cold—High cost to society. Allergy 65:776–783, 2010.

10.

Crystal-Peters

Crown

Goetzel

, The cost of productivity losses associated with allergic rhinitis. Am J Manag Care 6:373–378, 2000.

11.

Blaiss

. Allergic rhinitis: Direct and indirect costs. Allergy Asthma Proc 31:375–380, 2010.

12.

Kessler

Ormel

Demler

, Comorbid mental disorders account for the role impairment of commonly occurring chronic physical disorders: Results from the National Comorbidity Survey. J Occup Environ Med 45:1257–1266, 2003.

13.

Valovirta

Myrseth

and Palkonen

The voice of the patients: Allergic rhinitis is not a trivial disease. Curr Opin Allergy Clin Immunol 8:1–9, 2008.

14.

Simoens

and Laekeman

Pharmacotherapy of allergic rhinitis: A pharmaco-economic approach. Allergy 64:85–95, 2009.

15.

Bousquet

Neukirch

Bousquet

, Severity and impairment of allergic rhinitis in patients consulting in primary care. J Allergy Clin Immunol 117:158–162, 2006.

16.

Berk

Dodd

, The validity of the CGI severity and improvement scales as measures of clinical effectiveness suitable for routine clinical use. J Eval Clin Pract 14:979–983, 2008.

17.

International Rhinitis Management Working Group. International Consensus Report on the diagnosis and management of rhinitis. Allergy 49 (Suppl 19):1–34, 1994.

18.

Juniper

Stahl

Doty

, Clinical outcomes and adverse effect monitoring in allergic rhinitis. J Allergy Clin Immunol 115:S390–S413, 2005.

19.

Bousquet

Combescure

Neukirch

, Visual analog scales can assess the severity of rhinitis graded according to ARIA guidelines. Allergy 62:367–372, 2007.

20.

Guy

ECDEU Assessment Manual for Psychopharmacology. Bethesda, MD: National Institute of Mental Health, US Dept Health, Education and Welfare publication (ADM) 76–338; pp. 218–222, 1976.

21.

World Health Organization. WHO initiative on depression in public health. www.who.int/mental_health/management/depression/depressioninph/en/

22.

World Health Organization. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia. www.whqlibdoc.who.int/publications/2006/9241594934_eng.pdf

23.

Alonso

Prieto

and Anto

. The Spanish version of the SF-36 Health Survey (the SF-36 health questionnaire): an instrument for measuring clinical results. Med Clin (Barc) 104:771–776, 1995.

24.

Alonso

Regidor

Barrio

, Population reference values of the Spanish version of the Health Questionnaire SF-36. Med Clin (Barc) 111:410–416, 1998.

25.

Gawlicki

Reilly

Popielnicki

, Linguistic validation of the US Spanish work productivity and activity impairment questionnaire, general health version. Value Health 9:199–204, 2006.

26.

Reilly

Zbrozek

and Dukes

. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics 4:353–365, 1993.

27.

Lerner

Adler

Chang

, The clinical and occupational correlates of work productivity loss among employed patients with depression. J Occup Environ Med 46:S46–S55, 2004.

28.

Beck

Crain

Solberg

, Severity of depression and magnitude of productivity loss. Ann Fam Med 9:305–311, 2011.

29.

Berardi

Berti Ceroni

Leggieri

, Mental, physical, and functional status in primary care attenders. Int J Psychiatry Med 29:133–148, 1999.

30.

Erickson

Williams

and Gruppen

. Relationship between symptoms and health-related quality of life in patients treated for hypertension. Pharmacotherapy 24:344–350, 2004.

31.

Ogunlana

Adedokun

Dairo

, Profile and predictor of health-related quality of life among hypertensive patients in southwestern Nigeria. BMC Cardiovasc Disord 9:25, 2009.

32.

Erickson

Williams

and Gruppen

. Perceived symptoms and health-related quality of life reported by uncomplicated hypertensive patients compared to normal controls. J Hum Hypertens 15:539–548, 2001.

33.

American Diabetes Association. Economic costs of diabetes in the U.S. In 2007. Diabetes Care 31:596–615, 2008.

34.

Ramsey

Summers

Leong

, Productivity and medical costs of diabetes in a large employer population. Diabetes Care 25:23–29, 2002.

35.

Lavigne

Phelps

Mushlin

, Reductions in individual work productivity associated with type 2 diabetes mellitus. Pharmacoeconomics 21:1123–1134, 2003.

36.

Bousquet

Demarteau

Mullol

, Costs associated with persistent allergic rhinitis are reduced by levocetirizine. Allergy 60:788–794, 2005.

37.

Okubo

Gotoh

Shimada

, Fexofenadine improves the quality of life and work productivity in Japanese patients with seasonal allergic rhinitis during the peak cedar pollinosis season. Int Arch Allergy Immunol 136:148–154, 2005.

38.

Costa

Amouyal

Lambert

How representative are clinical study patients with allergic rhinitis in primary care?

J Allergy Clin Immunol 127:920–926 e921.

39.

Szeinbach

Seoane-Vazquez

Beyer

, The impact of allergic rhinitis on work productivity. Prim Care Respir J 16:98–105, 2007.

40.

Fireman

Treatment of allergic rhinitis: Effect on occupation productivity and work force costs. Allergy Asthma Proc 18:63–67, 1997.

41.

Leynaert

Neukirch

Liard

, Quality of life in allergic rhinitis and asthma. A population-based study of young adults. Am J Respir Crit Care Med 162:1391–1396, 2000.